Blogs about: Nexavar
Featured Blog
Phase II data shows Sorafenib to demonstrate efficacy in advanced thyroid cancer
Phase II data show sorafenib to demonstrate efficacy in patients with advanced thyroid carcinoma. The overall clinical benefit rate (partial response + stable disease) was 77% and the drug had an ac… more »
Kinase News
Abraxane (nab-paclitaxel) with or without Herceptin in First-Line Treatment of Metastatic Breast Cancer: ION 04-012 Study Results from the ASCO 2008 Annual Meeting
bmirtsching wrote 1 month ago: The International Oncology Network (ION) Study 04-012 results were presented in a poster presentatio … more »
Phase II data shows Sorafenib to demonstrate efficacy in advanced thyroid cancer
crimsoncanary wrote 1 month ago: Phase II data show sorafenib to demonstrate efficacy in patients with advanced thyroid carcinoma. … more »
Nexavar clinical data presented at ASCO
crimsoncanary wrote 1 month ago: Lung cancer - Phase II results show ‘encouraging’ results in heavily pre-treated patient … more »
Nexavar improves survival in liver cancer by 47percent
crimsoncanary wrote 2 months ago: Nexavar (sorafenib) has been shown to significantly improve overall survival by 47.3% in a phase III … more »
Sorafenib shows broader anti AML cell activity than Imatinib or Sunitinib
crimsoncanary wrote 2 months ago: In vitro analysis of multikinas inhibitors imatinib, sorafenib, and sunitinib in human AML cell line … more »
Living and Loving
— 1 comment
karmental wrote 2 months ago: “The next few months are for you to focus on living and loving” were Ann’s parting … more »
Nexavar with dacarbazine improves survival in advanced melanoma
crimsoncanary wrote 2 months ago: Results from a Phase II study show Nexavar (sorafenib), in combination with dacarbazine, improves pr … more »
The Elephant
— 2 comments
karmental wrote 2 months ago: I don’t know what to do or expect. It’s driving me crazy. Ignoring the obvious just … more »
Addition of Sorafenib to carboplatin/paclitaxel chemotherapy adds no benefit in lung cancer
crimsoncanary wrote 2 months ago: No benefit was observed in a trial evaluating the benefit of adding sorafenib (Nexavar) to a carbopl … more »
The High Road
— 3 comments
karmental wrote 3 months ago: Not a whole lot of news to report. Mom is continuing her radiation treatment and is taking the Nex … more »
Pharma News 2_2
Steve Woodruff wrote 5 months ago: After all that effort with alpha-blockers, beta-blockers, ACE inhibitors, etc….are we just goi … more »
Clinical Cancer Advances 2007
— 1 comment
danielteper wrote 6 months ago: The American Society of Clinical Oncology (ASCO) conducted its annual independant review and publis … more »
Celgene makes a move; Schering flips the birds to Wyeth
Steve Woodruff wrote 8 months ago: Looks, on the surface, like a good match of products and market presence - Celgene buys Pharmion. An … more »
Chemotherapy and Sorafenib (Nexavar) for First-Line Treatment of Metastatic Melanoma
bmirtsching wrote 9 months ago: The combination of carboplatin (Paraplatin) and paclitaxel (Taxol) is active in metastatic melanoma. … more »
Post-Operative (Adjuvant) Therapy for Completely Resected Renal (Kidney) Cancer
bmirtsching wrote 9 months ago: After complete surgical resection of localized renal cell carcinoma, there is no existing standard p … more »
nab-Paclitaxel (Abraxane) and sorafenib (Nexavar) for First-Line Treatment of Metastatic Breast Cancer
bmirtsching wrote 9 months ago: Barry C. Mirtsching, MD at CORT is the lead investigator for the International Oncology Network (ION … more »
Have your say. Start a blog.
See our free features »
Copyright 2008 Automattic, Inc.
An 
Invention
